Novavax, Inc. (NVAX)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreKey Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Mr. John Charles Jacobs M.B.A.
|
President, CEO & Director | 1.55M | -- | 1967 |
|
Mr. James Patrick Kelly C.F.A.
|
Executive VP, CFO & Treasurer | 884.28k | -- | 1966 |
|
Mr. Mark J. Casey Esq., J.D.
|
Executive VP, Chief Legal Officer & Corporate Secretary | 984.25k | -- | 1963 |
|
Ms. Elaine O'Hara
|
Executive VP & Chief Strategy Officer | 947.01k | -- | 1968 |
|
Mr. Richard P. Crowley
|
Executive VP & COO | -- | -- | 1957 |
|
Ms. Naina Zaman
|
Director of Investor Relations | -- | -- | -- |
|
Mr. Troy Morgan Esq., J.D.
|
Senior VP, Deputy General Counsel & Chief Compliance Officer | -- | -- | 1971 |
|
Ms. Erika S. Trahan
|
Associate Director of Investor & Public Relations | -- | -- | -- |
|
Mr. Ian J. Watkins
|
Executive VP & Chief Human Resources Officer | -- | -- | 1963 |
|
Ms. Silvia Taylor M.B.A.
|
Executive VP, Chief Corporate Affairs Officer & Head of Novavax Sweden | -- | -- | -- |
Novavax, Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 749
Description
Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Limited, and Serum Life Sciences Limited for the to develop, manufacture, and commercialize the COVID-19 vaccine. The company was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Corporate Governance
Upcoming Events
November 5, 2026 at 12:30 PM UTC
Novavax, Inc. Earnings Date
